Michael Wolfe
Michael Wolfe

Independent Director

Michael has over 30 years’ experience in finance, accounting, private equity and business valuation and has also served as a director for several private and public companies, including as a member of audit and other independent committees.

He is currently the CFO of Mind Cure Health Inc and was previously CFO of several mid-market Canadian companies including Baylin Technologies Inc., a TSX listed company in the wire communications industry.

And, brings a successful track record in acquisitions, management buyouts, growth financings and recapitalizations in diverse industries such as cable, broadcast, manufacturing, insurance, oil field services and global logistics through his work at General Partner at VenGrowth Capital Partners Inc.

Michael holds a CPA, CA designation, a Chartered Business Valuator designation, an MBA from McMaster University and a BA (Business and Economics) from the University of Western Ontario.

About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

With a focus on innovative approaches and committed to challenging the status quo, we’re targeting the root causes of depression and hoping to unlock the minds of millions.

Get Small Pharma updates

    Investor Deck

    Follow us: